ArticleCureus2025
Fiery Rash Revealing Hidden Hemochromatosis: A Case Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary hemochromatosis (HH) is an autosomal recessive genetic disorder characterized by excessive iron accumulation in tissues. This case highlights a 29-year-old man with an unusual presentation of hemochromatosis. Persistent symptoms led to bloodwork that revealed iron overload, prompting further genetic analysis. The 29-year-old Caucasian man presented to his primary care provider (PCP) with complaints of an erythematous and pruritic rash across his chest and abdomen. It was thought to be irritant contact dermatitis in congruence with his past medical history. He was treated with steroids with temporary improvement. He was also referred to dermatology, where he was started on dupilumab injections for eczema. Two weeks later, the patient visited the emergency department, presenting with an erythematous and pustular rash diffusely throughout both feet. His rash was assumed to be eczematous, and he was given steroids and antibiotics due to a few open sores observed. Upon returning to his PCP for follow-up, his routine labs revealed an elevated iron level of 208. In conjunction with his skin irritation, a cheek swab was ordered to check for the C282Y gene. This prompted his new diagnosis of HH. Upon this result, he was referred to hematology for further work-up. Magnetic resonance imaging (MRI) of the abdomen showed evidence of diffuse iron deposition in the liver. An echocardiogram and thyroid-stimulating hormone (TSH) levels were found to be normal in this patient. Treatment was explained, and he consented to start weekly phlebotomy to reduce total body iron stores. This case highlights an initial presentation that deviates from the typical rash and age group seen in hemochromatosis. Recognizing such manifestations may facilitate earlier diagnosis, and physicians should consider iron studies in patients with eczema or irritant dermatitis that is resistant or persistent despite standard therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.